American indices end the quarter in a very strong mood, driven by economic resilience and the unceasing boom in the technology sector. Despite local geopolitical turmoil, the "buying the dips" strategy remains the dominant approach among investors.
Key information from today's session and the last quarter
- Best quarter in years: S&P 500 ends its best quarter in six years. The three-month price increase expanded the market value of this index by an impressive 8 trillion dollars. Investor optimism is driven by a strong labor market and good consumer sentiment.
- Tech sector and AI on the offensive: Nasdaq 100 (US100) gains 1.6%. Meanwhile, the semiconductor manufacturers index (Philadelphia Semiconductor Index) is heading for its best quarter in history, supported by strong fundamentals and the structural trend of artificial intelligence (AI) development.
- June Swoon: Despite the great quarter, June itself brought a temporary deterioration in statistics: the S&P 500 index lost about 0.8% this month, but it is still a reduction of the drop from almost -5%. This is due to capital rotation towards smaller companies (small caps) and natural profit-taking after a massive, over 5% index growth in May.
- Geopolitics and falling oil prices: Markets are closely watching peace talks between the US and Iran being held in Qatar. Hopes for a permanent agreement and increased flows through the Strait of Hormuz have caused crude oil to head for its largest quarterly decline since the pandemic.
US100 gains strongly for the second session in a row and is only 1.5% away from historical highs. Source: xStation5
US500 remains in a slight loss in June. Source: xStation5
US OPEN: Nasdaq seals best quarter in years
"Rammmagedon” ends up in court: Antitrust lawsuit and investments in Korea
Daily summary: Semiconductors are swallowing Wall Street
IBM shows a breakthrough: Leader of the next revolution?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.